Your DNA contains the blueprint for how your body handles inflammation, repair, energy, and aging. GeneOS reads that blueprint — and turns it into a precise, personalized protocol. For you. For your patients.
One-time payment · Lifetime access · No subscription ever · Encrypted results delivered by our certified lab
GeneOS analyzes 18,000+ of your gene variants — how you metabolize nutrients, handle inflammation, respond to peptides, manage stress, and age. Then Hypatia AI builds you a personalized 12-week protocol. One test. For life.
Kit ships in 3–5 days · Results in ~3 weeks from lab receipt · No subscription required now or ever
Most AI in health is a chatbot in a lab coat. GeneOS is something else entirely — purpose-built clinical intelligence powered by a real academic lab team, 9,000 peer-reviewed studies, and 8.3M+ verified data points combined across Hypatia, Grok, Claude, and ChatGPT.
Underneath the premium language, it’s still broad-spectrum decision-making pretending to be customization. The ingredients change. The guesswork doesn’t.
“Personalized” protocols built on population averages and trend-driven ingredient selection, dressed up in clinical-sounding language. It looks sophisticated. It isn’t.
“Underneath the premium language, it’s still broad-spectrum decision-making pretending to be customization.”
Protocol design that starts with allelic configuration — the specific gene variants shaping how each patient handles inflammation, repair, energy, detox, and recovery. Once you can see the wiring, you stop guessing.
Each pillar builds on the last. Together, they give your clinical team a line from biology to intervention that no other platform can draw.
The specific gene variants that define how each patient handles inflammation, repair, energy production, detoxification, and recovery. Once you can see the wiring, protocol design stops being guesswork and starts becoming intelligent architecture.
→ 18,000+ variants mapped per patientFull exosome sequencing captures cellular signaling in real time — how the body is communicating now, where recovery is stalling, and which interventions fit the current biology. Predisposition tells you the potential. Exosome data tells you the present state. GeneOS accepts BAM, CRAM, FASTQ, and RNA-seq files directly — including targeted ribosome expression panels — and automatically scores pathway and pillar activation.
→ BAM · CRAM · FASTQ · RNA-seq · Ribosome ExpressionStructured, usable patient blueprints your clinical team can act on immediately. No bloated data dump. No science fair report. Just clear direction — organized by pathway, priority, and intervention window.
→ Delivered in <48 hoursIdentify the inputs most likely to activate the pathways tied to performance, resilience, tissue repair, metabolic efficiency, and stress adaptation. See what the patient is wired toward and what their system is primed to respond to right now.
→ Pathway activation targetingBespoke peptide stacks aligned to molecular need, not broad-spectrum guessing. Targeted intervention design built from the allelic and exosome profile. Tighter protocols, faster refinement, sharper outcomes.
→ Molecular-targeted, not trend-basedDelivery architecture matched to the intervention targets identified in the molecular profile. Every component has a biological reason. Every stack is a clinical decision, not a product bundle.
→ Delivery matched to molecular targetsFive clinical stages. Zero guesswork. Every decision grounded in that patient’s biology.
Collect genetics, baseline labs, health history. Order a GeneOS kit or upload existing genomic data — including BAM/FASTQ files from prior sequencing runs.
Hypatia AI processes the full biological dataset — gene variants and real-time cellular signaling together.
Structured report delivered to your clinical team in under 48 hours. Clear, actionable, zero noise.
Peptide matrix + smart patch stack designed precisely to the molecular profile. Not a standard stack.
Ongoing exosome tracking and protocol optimization. The protocol adapts as the biology responds.
GeneOS provides your clinical team with the complete DNA + ribosome expression kit, in-house lab processing, and the AI platform to turn raw genomic data into patient-specific interventions. No guesswork. No generic stacks. Clear molecular direction for every patient.
We supply the full DNA + ribosome expression collection kit directly to you or your patients. Our lab processes every sample and delivers encrypted results to your clinical dashboard — no third-party lab coordination required.
Stop guessing at hormone, peptide, and supplement doses. GeneOS maps each patient’s CYP450 enzyme variants, receptor sensitivity, and metabolic pathways — so every dose has a molecular rationale behind it, not a population average.
New genomic research changes what variants mean clinically — every day. Hypatia absorbs new studies automatically so your protocols reflect the current science, not last year’s textbook.
Every clinical subscription includes full API access. Connect GeneOS directly into your EHR, CRM, or practice management system — pull your entire token vault, manage patient tokens, and trigger webhooks on results-ready events. No extra cost, no integration fees.
Kit pricing, volume discounts, and platform access are tailored to your practice size. Let’s talk about what that looks like for your team.
📅 Request a Clinical Meeting →“I’ve done 23andMe, Ancestry, everything. They all tell me the same ten lifestyle tips. GeneOS was the first time I actually understood what was happening in my biology. Finding out my COMT variants explained fifteen years of anxiety — and then fixing it with the right protocol — that’s not a supplement stack. That’s precision.”Marcus T. Biohacker · Austin, TX DNA Kit Customer · Bio-age: 31 at 38
“The thing nobody tells you about generic DNA tests is that they’re not personalized at all — they’re population statistics. My GeneOS blueprint showed MTHFR heterozygous, APOE ε3/ε4, high-impact COMT. The protocol Hypatia built for me was nothing like what I’d been taking. Eight weeks in, my inflammation markers are the best they’ve been in years.”Sarah K. Health Optimizer · Denver, CO DNA Kit Customer · Lifetime Access Since 2026
“We spent years thinking we were doing personalized medicine. We weren’t. GeneOS showed us what it actually looks like when you can see a patient’s allelic wiring before you design a protocol. Our retention numbers haven’t been the same since.”Dr. Nathan Kessler, MD Regenerative Medicine & Performance Kessler Performance Health — Denver, CO
“The exosome sequencing layer changed how I think about intervention timing entirely. Predisposition tells you what might happen. Real-time signaling tells you what’s happening right now. That gap is where most clinics lose the patient — and where GeneOS gives you the edge.”Dr. Jennifer Holloway, MD, PhD Functional & Precision Medicine Holloway Biomarker Institute — San Francisco, CA
“My team stopped guessing. That’s the simplest way I can put it. We get a blueprint, we build to it, we track the exosome response, and we refine. The protocols are tighter, the outcomes are sharper, and patients feel the difference.”Dr. Sarah Winthrop, MD Integrative & Longevity Medicine Winthrop Longevity Partners — Austin, TX
The world’s best genomics clinician would need to hold 35 million peer-reviewed papers, 200 million AlphaFold protein structure predictions, decades of Russian peptide institute research that never made it into Western journals, and 18,000+ gene-to-pathway associations — in their head, simultaneously, for every patient. Then update it every day as new science rewrites what variants mean clinically.
No human can do that. Hypatia does. And when a new study changes the clinical picture for a variant your patients carry, every protocol that variant touches updates automatically.
Hypatia isn’t a single AI. It’s a coordinated team of domain specialists that work in parallel — each drawing from a different body of evidence that no human team could synthesize in real time.
Interprets allelic configurations across MTHFR, APOE, CYP450, COMT, and 18,000+ pathways. Pulls from ClinVar (1.2M+ variant classifications), GWAS Catalog (500K+ associations), and gnomAD (140K population genomes) to identify what your specific combination means clinically — not just statistically.
Processes raw ribosome expression and sequencing data, normalizes variant calls, and surfaces high-impact signal patterns using AlphaFold protein structure predictions — identifying protein-level interactions no symptom-based approach could catch.
Maps biomarker patterns — hormones, cytokines, inflammatory markers — to their allelic drivers. Draws from 35M+ indexed PubMed studies to identify which of your genetic variants are producing which measurable signals in your bloodwork right now.
Commands one of the world’s most comprehensive peptide databases — including pre-glasnost Russian institute research on Epitalon, BPC-157, Thymalin, and Selank that most Western researchers have never accessed. Matches peptide compounds to your exact allelic profile and pathway priorities.
Translates genetic findings into precision nutrition. Which nutrient forms your MTHFR variants can actually use. Which foods your CYP enzymes metabolize correctly. Which cofactors your specific methylation pathway needs. Not general advice — your biology.
Translates complex genomic findings into clinical language your patients can act on. Identifies contraindications between your allelic profile and standard interventions — things a standard consultation would never catch without your genetic data in front of them.
All seven specialists update in parallel as new research publishes. When a study rewrites what a variant means clinically — which happens daily across PubMed, AlphaFold updates, and our proprietary peptide database — every affected blueprint reflects it automatically.
Our interactive demo walks through a real patient analysis — allelic configuration, genetic blueprint, peptide matrix, and protocol — so you know exactly what you’re getting before you order.
🧬 Launch Interactive Demo →No account required · See real analysis in under 3 minutes
Our demo walks through an actual genetic analysis end-to-end — allelic configuration, blueprint, peptide matrix, and dosing rationale. See exactly what you’re getting before you order.
Individuals get lifetime access for a single one-time payment. Clinical practices get custom kit pricing and platform access tailored to their patient volume — contact us to build the right package.
Ships in 3–5 days · Results in ~3 weeks from lab receipt
Clinical pricing is based on your practice size, kit volume, and platform needs. We build a package that fits — no forcing a subscription that doesn’t match your patient load.
Kit volume, platform access, and pricing tailored to your practice. No call centre — you meet directly with our team.
💬 Request a Clinical MeetingNot sure which is right for you? If you want to understand your own DNA — order the individual kit. If you run a practice and want to offer genetic precision to your patients — reach out and we’ll put together the right clinical package. Questions?
Watch how GeneOS transforms a patient intake into a precision intervention. No guesswork. No generic stacks. Just clear biological direction.
Meet with our clinical team to see how GeneOS maps to your patient workflow. No sales pitch — just the platform, live, on your timeline. We’ll assign the right team member based on availability.